Form 8-K - Current report:
SEC Accession No. 0001104659-25-024505
Filing Date
2025-03-17
Accepted
2025-03-17 17:20:03
Documents
13
Period of Report
2025-03-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259546d1_8k.htm   iXBRL 8-K 31261
  Complete submission text file 0001104659-25-024505.txt   207224

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxi-20250317.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20250317_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20250317_pre.xml EX-101.PRE 22359
15 EXTRACTED XBRL INSTANCE DOCUMENT tm259546d1_8k_htm.xml XML 3668
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 25745658
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)